LOGO
LOGO

Breaking News

Interesting Stocks To Watch - Nov. 6: TRNX, EXAM, NSR, TACT, SBAC, LF, CVD, MYGN

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

What makes these stocks interesting?

Tornier N.V (TRNX) Sees Q4, FY12 Sales Above Consensus

- Projects Q4 sales in the range of $75.8 mln - $78.8 mln. Consensus - $72.47 mln.

- Expects FY12 sales to range between $274 mln and $277 mln. Consensus - $270.98 mln.

***

ExamWorks Group Inc. (EXAM) Expects Q4, FY12 Sales Above Estimates

- Sees Q4 reported revenue to range between $138 mln and $142 mln. Consensus - $136.00 mln.

- Projects FY12 reported revenue in the range of $520 mln - $524 mln.

- Expects FY12 pro forma revenue to range between $575 mln and $579 mln. Consensus - $516.12 mln.

- Expects FY13 organic revenue growth to increase to between 5% and 7%.

***

NeuStar Inc. (NSR) Q3 Profit Rises; Lifts FY12 Earnings View

- Raises FY12 adj. EPS target to $2.94 - $3.03 from prior outlook of $2.78 - $2.90 per share. Consensus - $2.85/Shr.

- Now sees FY12 adj. net income in the range of $200 mln - $206 mln, up from prior view of $189 mln - $197 mln.

- Maintains FY12 revenue guidance at $825 mln - $835 mln. Consensus - $830.93 mln.

***

Pike Electric Corp. (PIKE) Q1 Profit Up, Tops View

- Q1 EPS surged to $0.26 from $0.07 last year. Consensus - $0.12/Shr.

- Q1 net income rose to $9.28 mln from $2.60 mln last year.

- Q1 revenues increased to $244.6 mln from $171.8 mln a year ago. Consensus - $198.37 mln.

***

TransAct Technologies Inc. (TACT) Issues Q4 Guidance

- Sees Q4 EPS, excluding the AVY legal fees, to be at least $0.20. Year ago EPS was $0.06/Shr.

- Projects Q4 revenue to be at least $19 mln. Year ago revenue was $13.65 mln.

***

SBA Communications Corp. (SBAC) Q3 FFO Rises; Lifts FY12 Revenue Outlook

- Projects Q4 adj. FFO in the range of $107 mln - $111 mln.

- Expects Q4 revenues to range between $285.5 mln and $289.5 mln. Consensus - $276.33 mln.

- Lifts FY12 adj. FFO target to $371.4 mln - $375.4 mln from prior outlook of $338 mln - $371 mln.

- Raises FY12 revenue guidance to $945.7 mln - $949.7 mln from prior view of $881 mln - $911 mln. Consensus - $933.77 mln.

- Expects FY13 adj. FFO in the range of $456.0 mln - $476.0 mln

- Sees FY13 revenue to range between $1.16 bln and $1.19 bln. Consensus - $1.18 bln.

***

Performant Financial Corp. (PFMT) Q3 Profit Rises

- Q3 net income rose to $6.4 mln or $0.13/Shr from $3.5 mln or $0.08/Shr last year.

- Q3 adj. net income was $8.1 mln or $0.17/Shr versus $7 mln or $0.16/Shr a year ago.

- Q3 revenues increased 27.1% to $53.4 mln from $42 mln last year.

***

LeapFrog Enterprises Inc. (LF) Q3 Results Tops Estimate; Boosts FY12 Outlook

- Now sees FY12 EPS in the range of $0.75 - $0.81 from prior view of $0.61 - $0.66. Consensus - $0.68/Shr.

- Now expects FY12 net sales to increase 18% - 21% to $535 mln - $550 mln versus prior growth estimate of 13% - 15%. Consensus - $533.88 mln.

***

Andersons Inc. (ANDE) Q3 Profit Rises

- Q3 net income was $16.9 mln or $0.90/Shr versus $10.9 mln or $0.59/Shr last year. Consensus - $0.27/Shr.

- Q3 revenues rose to $1.14 bln from $938.7 mln last year. Consensus - $982.20 mln.

***

Covance Inc. (CVD) Q3 Profit Tops View; Revises FY12 EPS Outlook

- Sees Q4 pro forma EPS to be about $0.70. Consensus - $0.69/Shr.

- Lifts lower-end of FY12 EPS target to a range of $2.65 - $2.70, from prior estimate of $2.50 - $2.70/Shr. Consensus - $2.61/Shr.

***

Fidelity National Financial Inc. (FNF) Q3 Profit Increases

- Q3 net income was $233.3 mln or $1.03/Shr, up from $74.3 mln or $0.33/Shr last year. Consensus - $0.54/Shr.

- Q3 total revenues grew to $2.04 bln from $1.20 bln last year.

***

Rudolph Technologies Inc. (RTEC) Q3 Profit Up On Higher Revenues

- Q3 net income was $6.66 mln or $0.20/Shr versus $5.30 mln or $0.16/Shr last year. Consensus - $0.23/Shr.

- Q3 revenues rose to $62.2 mln from $41.4 mln a year ago. Consensus - $60.15 mln.

***

Myriad Genetics Inc. (MYGN) Q3 Results Top Estimate; Boosts FY13 Outlook

- Lifts FY13 EPS target to $1.50 - $1.55 from prior outlook of $1.44 - $1.48. Consensus - $1.47/Shr.

- Raises FY13 revenue guidance to $570 mln - $585 mln from prior estimate of $550 mln - $565 mln. Consensus - $563.46 mln.

***

Medifast Inc. (MED) Sees Q4 Results Above Consensus

- Expects Q4 EPS to range between $0.23 and $0.25. Consensus - $0.19/Shr.

- Projects Q4 net revenue to increase in the range of 18% - 21% or $82 mln - $84 mln. Consensus - $80.22 mln.

***

BIOLASE Inc. (BIOL) Issues Q4, FY12 Guidance

- Projects Q4 net revenue to be about $16.5 mln - $17.5 mln, reflecting expected growth of 26% - 34% over last year. Consensus - $17.90 mln.

- Expects FY12 non-GAAP adj. gross revenue in the range of $55 mln - $58 mln. Consensus - $56.97 mln.

- Sees FY12 GAAP revenue in the range of $53.9 mln - $56.9 mln.

***

Alon USA Energy Inc. (ALJ) Q3 Profit Rises

- Q3 net income rose to $43.2 mln or $0.76/Shr from $28.6 mln or $0.51/Shr last year.

- Q3 net income, excl. special items, was $47.6 mln or $0.84/Shr, up from $39.0 mln or $0.70/Shr last year. Consensus - $0.64/Shr.

- Q3 net sales were $2.36 bln, up from $2.06 bln generated a year ago. Consensus - $2.05 bln.

***

ePlus inc. (PLUS) Q2 Profit Increases

- Q2 net income rose 42% to $10 mln from $7.1 mln last year.

- Q2 EPS grew 49.4% to $1.27 from $0.85 last year.

- Q2 revenues increased 27.7% to $260.1 mln from $203.7 mln last year.

***

Vectren Corp. (VVC) Q3 Profit Tops Estimate; Boosts FY12 EPS Outlook

- Raises FY12 EPS target to $1.80 - $1.90 from prior guidance of $1.65 - $1.85. Consensus - $1.74/Shr.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.

RELATED NEWS